Rallybio Anticipates Merger Closing After Nov. 20 Trading
Rallybio expects to begin distributing $13.90 per share in cash on Nov. 30, 2026.
Story updates
10:01:29 PM UTC
SquawkNews
Rallybio Expects Avenzo Therapeutics Merger to Close November 20, 2026 Rallybio's merger with Av